ArticleNature materials2026
Quasi-non-volatile capacitorless DRAM based on ultralow-leakage edge-contact MoS
Article in Nature materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Two-dimensional materials for advanced back-end-of-line and wafer backside technologies.Nature nanotechnology · 2026Review
- In-Sensor-Memory Computing for Post-Von Neumann Intelligence: A Perspective.Nano-micro letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Funding
Abstract
Two-dimensional semiconductors are emerging as crucial materials for the post-Moore era. However, the transition to industrial-scale applications is hindered by engineering challenges, including the contact engineering. Among different strategies, edge contact offers advantages of ultimate contact scaling and the elimination of Fermi level pinning, but struggles with co-optimization between on-state current, threshold voltage and off-state leakage current. Here we address these challenges by utilizing an in situ multistep process, in which etching, soft plasma treatment and metal deposition are performed sequentially within the same custom-designed high-vacuum chamber to minimize interface defects. This approach enables molybdenum disulfide (MoS
Identifiers
41535330What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.